QuickView for ALOX5;jsessionid=AFF6120FA143E6EBD2F0BCA771726146;jsessionid=573033D10AB51B41C198EFDFD62F126A;jsessionid=9687D3E8BB1DBC6A040D88178EA0A1E3;jsessionid=813A3499AAFE52CB0E89BD46985D6ECE;jsessionid=D33C90F5166BE8116244013719EBA8B5;jsessionid=1315A27005ED06EC043EBDBDF26FBEE0;jsessionid=A095B431995880418427C948464EF475 (gene)

1. ALOX5 deficiency contributes to bladder cancer progression by mediating ferroptosis escape.
2. ALOX5 drives the pyroptosis of CD4+ T cells and tissue inflammation in rheumatoid arthritis.
3. Osteomesopyknosis associated with a novel ALOX5 variant that impacts the RANKL pathway.
4. Structure and ligand based design for identification of highly potent molecules against 5-LOX.
5. ALOX5-mediated ferroptosis acts as a distinct cell death pathway upon oxidative stress in Huntington…

There were no clinical trials for ALOX5;jsessionid=AFF6120FA143E6EBD2F0BCA771726146;jsessionid=573033D10AB51B41C198EFDFD62F126A;jsessionid=9687D3E8BB1DBC6A040D88178EA0A1E3;jsessionid=813A3499AAFE52CB0E89BD46985D6ECE;jsessionid=D33C90F5166BE8116244013719EBA8B5;jsessionid=1315A27005ED06EC043EBDBDF26FBEE0;jsessionid=A095B431995880418427C948464EF475